HS Code 3002 - Other Europe Nes Exports of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-organisms (excluding Yeasts) And Similar Products

Reporting Year

Opportunity Index Competition Index World Consumption Pattern Monthly Consumption Pattern Focus Markets

Opportunity Index

Other Europe nes’s Annual Export of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products Vs. World Consumption

There is an opportunity of increasing Other Europe nes’s Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products exports to the world by times. The product presents a potential export opportunity of $ for Other Europe nes exporters.

Other Europe nes’s Export $ Demand Supply Gap $
Opportunity Index (OI)

Measurement of Other Europe nes’s Export Potential of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products To World’s Top 10 Importers of The Product

Country	Import Value	Other Europe nes Export Value	Opportunity Index (OI)

Country	Import Value	Other Europe nes Export Value	Opportunity Index(OI)

Prospects for market diversification of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products

	CY2011		CY2023
Country	Imports	Exports	Imports	Exports	Diversification	Imports Growth	Exports Growth

Country	2011 Exports	2023 Exports	Difference

Competition Index

Level of Competition Faced By Other Europe nes From 10 Biggest Exporters of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products

World Consumption Pattern

Biggest Importers of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products

3002 (Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products)

Connections (0)

Monthly Consumption Patterns

Monthly Consumption Patterns of Top 10 Importers of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products (By Value In $)

Importers	Jan-2023	Feb-2023	Mar-2023	Apr-2023	May-2023	June-2023	July-2023	Aug-2023	Sep-2023	Oct-2023	Nov-2023	Dec-2023

An analysis of monthly consumption patterns of top 10 importers of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products (by value) reveals that consumption fluctuates during the year and is "seasonal" in almost all the markets.

Importers	Jan-2023	Feb-2023	Mar-2023	Apr-2023	May-2023	June-2023	July-2023	Aug-2023	Sep-2023	Oct-2023	Nov-2023	Dec-2023

An analysis of monthly consumption patterns of top 10 importers of Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products (by volume) shows that consumption fluctuates during the year and is “seasonal” in almost all the markets.

Focus Markets

Other Europe nes’s Top Focus Markets For Human Blood; Animal Blood Prepared For Therapeutic, Prophylactic Or Diagnostic Uses; Antisera And Other Blood Fractions And Modified Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines, Toxins, Cultures Of Micro-Organisms (Excluding Yeasts) And Similar Products Country-Wise Share In Other Europe nes’s Exports (In Value Terms)

Country-Wise Share In Other Europe nes’s Exports (In Percentage Terms)

Top Destinations Between CY 2011 and CY 2023